Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane

Nature Chemical Biology

Volumn 8, Issue 4, 2012, Pages 334-341

  Grzegorzewicz, Anna E ^a   Pham, Ha ^a   Gundi, Vijay A K B ^a   Scherman, Michael S ^a   North, Elton J ^b   Hess, Tamara ^a   Jones, Victoria ^a   Gruppo, Veronica ^a   Born, Sarah E M ^a   Korduláková, Jana ^c   Chavadi, Sivagami Sundaram ^a   Morisseau, Christophe ^d,e   Lenaerts, Anne J ^a   Lee, Richard E ^b   McNeil, Michael R ^a   Jackson, Mary ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c Physics and Informatics   (Slovakia)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMANTYL UREA; ARABINOGALACTAN; AU 1235; BACTERIAL PROTEIN; GLYCOLIPID; MMPL3 PROTEIN; MYCOLIC ACID; TREHALOSE; TREHALOSE MONOMYCOLATE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERIAL TRANSLOCATION; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; CYTOPLASM; FATTY ACID TRANSPORT; GENE EXPRESSION; GENE SEQUENCE; MUTANT; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

CORYNEBACTERINEAE; MYCOBACTERIUM TUBERCULOSIS;

EID: 84858677107     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.794     Document Type: Article

References (49)

1. World Health Organization. Global Tuberculosis Control - Epidemiology, Strategy, Financing (World Health Organization, 2009).
2. Global Alliance for TB Drug Development. Scientific blueprint for TB drug development. Tuberculosis (Edinb.) 81, 1-52 (2001).
3. Center for Disease Control and Prevention (CDC). Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs worldwide, 2000-2004. MMWR Morb. Mortal. Wkly. Rep. 55, 301-305 (2006).
4. Schroeder, E.K., de Souza, O.N., Santos, D.S., Blanchard, J.S. & Basso, L.A. Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis. Curr. Pharm. Biotechnol. 3, 197-225 (2002). (Pubitemid 34823018)
5. Barry, C.E., Crick, D.C. & McNeil, M.R. Targeting the formation of the cell wall core of Mycobacterium tuberculosis. Infect. Disord. Drug Targets 7, 182-202 (2007). (Pubitemid 47099127)
6. Alahari, A. et al. Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria. PLoS ONE 2, e1343 (2007).
7. Daffé, M. & Draper, P. The envelope layers of mycobacteria with reference to their pathogenicity. Adv. Microb. Physiol. 39, 131-203 (1998). (Pubitemid 29077883)
8. Barry, C.E. III et al. Mycolic acids: structure, biosynthesis and physiological functions. Prog. Lipid Res. 37, 143-179 (1998). (Pubitemid 28391410)
9. Dubnau, E. et al. Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice. Mol. Microbiol. 36, 630-637 (2000). (Pubitemid 30258847)
10. Glickman, M.S. Cording, cord factors and trehalose dimycolate. in The Mycobacterial Cell Envelope (eds. Daffé, M. & Reyrat, J.-M.) 63-73 (ASM Press, 2008).
11. Hoffmann, C., Leis, A., Niederweis, M., Plitzko, J.M. & Engelhardt, H. Disclosure of the mycobacterial outer membrane: cryo-electron tomography and vitreous sections reveal the lipid bilayer structure. Proc. Natl. Acad. Sci. USA 105, 3963-3967 (2008). (Pubitemid 351723507)
12. Zuber, B. et al. Direct visualization of the outer membrane of mycobacteria and corynebacteria in their native state. J. Bacteriol. 190, 5672-5680 (2008).
13. Vander Beken, S. et al. Molecular structure of the Mycobacterium tuberculosis virulence factor, mycolic acid, determines the elicited inflammatory pattern. Eur. J. Immunol. 41, 450-460 (2011).
14. Takayama, K., Wang, C. & Besra, G.S. Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin. Microbiol. Rev. 18, 81-101 (2005). (Pubitemid 40170662)
15. Gavalda, S. et al. The Pks13/FadD32 crosstalk for the biosynthesis of mycolic acids in Mycobacterium tuberculosis. J. Biol. Chem. 284, 19255-19264 (2009).
16. Lea-Smith, D.J. et al. The reductase that catalyzes mycolic motif synthesis is required for efficient attachment of mycolic acids to arabinogalactan. J. Biol. Chem. 282, 11000-11008 (2007). (Pubitemid 47100777)
17. Bhatt, A., Brown, A.K., Singh, A., Minnikin, D.E. & Besra, G.S. Loss of a mycobacterial gene encoding a reductase leads to an altered cell wall containing beta-oxo-mycolic acid analogs and accumulation of ketones. Chem. Biol. 15, 930-939 (2008).
18. Woodruff, P.J. et al. Trehalose is required for growth of Mycobacterium smegmatis. J. Biol. Chem. 279, 28835-28843 (2004). (Pubitemid 38915750)
19. Murphy, H.N. et al. The OtsAB pathway is essential for trehalose biosynthesis in Mycobacterium tuberculosis. J. Biol. Chem. 280, 14524-14529 (2005). (Pubitemid 40562794)
20. Tropis, M. et al. The crucial role of trehalose and structurally related oligosaccharides in the biosynthesis and transfer of mycolic acids in Corynebacterineae. J. Biol. Chem. 280, 26573-26585 (2005). (Pubitemid 41022255)
21. Kalscheuer, R., Weinrick, B., Veeraraghavan, U., Besra, G.S. & Jacobs, W.R. Jr. Trehalose-recycling ABC transporter LpqY-SugA-SugB-SugC is essential for virulence of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 107, 21761-21766 (2010).
22. Besra, G.S. et al. Identification of the apparent carrier in mycolic acid synthesis. Proc. Natl. Acad. Sci. USA 91, 12735-12739 (1994).
23. Sathyamoorthy, N. & Takayama, K. Purification and characterization of a novel mycolic acid exchange enzyme from Mycobacterium tuberculosis. J. Biol. Chem. 262, 13417-13423 (1987).
24. Belisle, J.T. et al. Role of the major antigen of Mycobacterium tuberculosis in the cell wall biogenesis. Science 276, 1420-1422 (1997). (Pubitemid 27235411)
25. Jackson, M. et al. Inactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope. Mol. Microbiol. 31, 1573-1587 (1999). (Pubitemid 29110112)
26. Puech, V. et al. Evidence for a partial redundancy of the fibronectin-binding proteins for the transfer of mycoloyl residues onto the cell wall arabinogalactan termini of Mycobacterium tuberculosis. Mol. Microbiol. 44, 1109-1122 (2002). (Pubitemid 34535544)
27. Sanki, A.K., Boucau, J., Ronning, D.R. & Sucheck, S.J. Antigen 85C-mediated acyl-transfer between synthetic acyl donors and fragments of the arabinan. Glycoconj. J. 26, 589-596 (2009).
28. Brown, J.R. et al. The structure-activity relationship of urea derivatives as anti-tuberculosis agents. Bioorg. Med. Chem. 19, 5585-5595 (2011).
29. Camacho, L.R. et al. Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier. J. Biol. Chem. 276, 19845-19854 (2001).
30. Morisseau, C. & Hammock, B.D. Epoxide hydrolases: Mechanisms, inhibitor designs, and biological roles. Annu. Rev. Pharmacol. Toxicol. 45, 311-333 (2005). (Pubitemid 40261808)
31. Jain, M., Chow, E.D. & Cox, J.S. The MmpL protein family. in The Mycobacterial Cell Envelope (eds. Daffé, M. & Reyrat, J.-M.) 201-210 (ASM Press, 2008).
32. Domenech, P., Reed, M.B. & Barry, C.E. III. Contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistance. Infect. Immun. 73, 3492-3501 (2005). (Pubitemid 40745893)
33. Tekaia, F. et al. Analysis of the proteome of Mycobacterium tuberculosis in silico. Tuber. Lung Dis. 79, 329-342 (1999).
34. De Rossi, E., Ainsa, J.A. & Riccardi, G. Role of mycobacterial efflux transporters in drug resistance: an unsolved question. FEMS Microbiol. Rev. 30, 36-52 (2006).
35. Saier, M.H. Jr. & Paulsen, I.T. Phylogeny of multidrug transporters. Semin. Cell Dev. Biol. 12, 205-213 (2001).
36. Murakami, S. Multidrug efflux transporter, AcrB-the pumping mechanism. Curr. Opin. Struct. Biol. 18, 459-465 (2008).
37. Sennhauser, G., Bukowska, M.A., Briand, C. & Grutter, M.G. Crystal structure of the multidrug exporter MexB from Pseudomonas aeruginosa. J. Mol. Biol. 389, 134-145 (2009).
38. Cox, J.S., Chen, B., McNeil, M. & Jacobs, W.R. Jr. Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature 402, 79-83 (1999).
39. Converse, S.E. et al. MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence. Proc. Natl. Acad. Sci. USA 100, 6121-6126 (2003). (Pubitemid 36576941)
40. Domenech, P. et al. The role of MmpL8 in sulfatide biogenesis and virulence of Mycobacterium tuberculosis. J. Biol. Chem. 279, 21257-21265 (2004). (Pubitemid 38656531)
41. Gilleron, M. et al. Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis. J. Exp. Med. 199, 649-659 (2004). (Pubitemid 38316432)
42. Tullius, M.V. et al. Discovery and characterization of a unique mycobacterial heme acquisition system. Proc. Natl. Acad. Sci. USA 108, 5051-5056 (2011).
43. Jackson, M., Stadthagen, G. & Gicquel, B. Long-chain multiple methyl-branched fatty acid-containing lipids of Mycobacterium tuberculosis: biosynthesis, transport, regulation and biological activities. Tuberculosis (Edinb.) 87, 78-86 (2007). (Pubitemid 46217257)
44. Jain, M. & Cox, J.S. Interaction between polyketide synthase and transporter suggests coupled synthesis and export of virulence lipid in M. tuberculosis. PLoS Pathog. 1, e2 (2005).
45. Jackson, M., Camacho, L.R., Gicquel, B. & Guilhot, C. Gene replacement and transposon delivery using the negative selection marker sacB. Methods Mol. Med. 54, 59-75 (2001).
46. Guo, X.V. et al. Silencing essential protein secretion in Mycobacterium smegmatis by using tetracyclin repressors. J. Bacteriol. 189, 4614-4623 (2007). (Pubitemid 47025573)
47. Korduláková, J. et al. Definition of the first mannosylation step in phosphatidylinositol synthesis: PimA is essential for growth of mycobacteria. J. Biol. Chem. 277, 31335-31344 (2002). (Pubitemid 34968932)
48. Stadthagen, G. et al. p-hydroxybenzoic acid synthesis in Mycobacterium tuberculosis. J. Biol. Chem. 280, 40699-40706 (2005). (Pubitemid 41780561)
49. Leistikow, R.L. et al. The Mycobacterium tuberculosis DosR regulon assists in metabolic homeostasis and enables rapid recovery from nonrespiring dormancy. J. Bacteriol. 192, 1662-1670 (2010).